scholarly journals Role of Contrast Enhancement and Corrected Attenuation Values of Renal Tumors in Predicting Renal Cell Carcinoma (RCC) Subtypes: Protocol for a Triphasic Multi-Slice Computed Tomography (CT) Procedure

2017 ◽  
Vol 82 ◽  
pp. 384-391 ◽  
Author(s):  
Ersen Ertekin ◽  
Akın Soner Amasyalı ◽  
Bulent Erol ◽  
Saim Acikgozoglu ◽  
Faruk Kucukdurmaz ◽  
...  
Biomolecules ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 664
Author(s):  
Julia Bohosova ◽  
Adela Kubickova ◽  
Ondrej Slaby

LncRNA PVT1 (plasmacytoma variant translocation 1) has become a staple of the lncRNA profile in patients with renal cell carcinoma (RCC). Common dysregulation in renal tumors outlines the essential role of PVT1 in the development of RCC. There is already a plethora of publications trying to uncover the cellular mechanisms of PVT1-mediated regulation and its potential exploitation in management of RCC. In this review, we summarize the literature focused on PVT1 in RCC and aim to synthesize the current knowledge on its role in the cells of the kidney. Further, we provide an overview of the lncRNA profiling studies that have identified a more or less significant association of PVT1 with the clinical behavior of RCC. Based on our search, we analyzed the 17 scientific papers discussed in this review that provide robust support for the indispensable role of PVT1 in RCC development and future personalized therapy.


Author(s):  
Elif Gündoğdu ◽  
Emre Emekli ◽  
Ersoy Acer ◽  
İlter Özer

Background: Birt-Hogg-Dubé Syndrome (BHDS), an autosomal dominant hereditary condition, occurs due to mutations in the gene encoding folliculin (FLCN) in the short arm of the 17th chromosome characterized by lung cysts with specific skin findings and renal cell carcinoma. Patients are usually present with complaints of dyspnea and chest pain due to pneumothorax, but also may be asymptomatic due to wide phenotypic heterogeneity. Herein, we report the imaging findings of a case 32-year-old male with BHDS without any symptom who diagnosed incidentally by computed tomography (CT) because of being organ donation. Case Report: In a 32-year-old male patient evaluated as a potential liver donor, CT was performed for preoperative preparation. The patient's medical history was unremarkable. In the CT examination, multiple air cysts of different sizes in the both lungs were observed and also, a 7-cm solid renal mass of the right kidney was observed in the dynamic examination. Due to the large number of lung cysts and the presence of solid renal tumors at a young age, BHDS was considered. The patient underwent partial nephrectomy and the pathology result was hybrid oncocytic-chromophobe renal cell carcinoma. In the genetic examination, a heterozygous germline mutation was detected in the 11th exon of the FLCN gene. Conclusion: While potential organ donors are generally healthy and asymptomatic individuals, incidental lesions can be detected in the donor organ or other organs in the examination area during radiological imaging. Although most incidental lesions are benign, important clinical conditions can be rarely observed, as in our case. Familial and syndromic conditions should also be kept in mind in the presence of solid renal masses incidentally detected at a young age. To the best of our knowledge, this is the first reported case of BHDS in English literature who was diagnosed incidentally on computed tomography for being living liver donor.


2005 ◽  
Vol 3 (1) ◽  
pp. 95-102 ◽  
Author(s):  
Michael P. Porter ◽  
Paul H. Lange

Renal tumors are a common cause of cancer, and renal cell carcinoma accounts for the vast majority of the renal tumors in the United States. The past two decades have produced numerous advances in the treatment of localized and metastatic renal cell carcinoma. Nephron-sparing surgery, laparoscopic nephrectomy, and energy-ablative techniques are now in the armamentarium of the urologist. The role of adrenalectomy and lymphadenectomy are better understood today than in decades past, and recent advances in the understanding of immunotherapy, cytoreductive nephrectomy, and metastatic disease have also improved treatment for this disease. As is often the case as technology and knowledge evolve, controversies regarding the surgical treatment of renal cancer exist. This article outlines some of these controversies and reviews the evidence surrounding each.


2020 ◽  
Vol 12 (214) ◽  
pp. 74-78
Author(s):  
Elena Filimonova ◽  
◽  
Alexander Aleshkevich

The article describes the use of the developed diagnostic complex of kidney cancer using computed tomography. A personalized approach to the examination of the patient and a detailed analysis of the main characteristics of the kidney neoplasm are the grounds for choosing at the preoperative stage a certain variant of organ-preserving surgery.


2017 ◽  
Vol 48 (3) ◽  
pp. 677-685
Author(s):  
Ahmad Hafez Ahmad Afifi ◽  
Eman Mohamad Ahmad ◽  
Ashraf Naguib Etaby ◽  
Mohamad Adel Atta ◽  
Sherif Farouk Elzawawi

1986 ◽  
Vol 10 (4) ◽  
pp. 183-188
Author(s):  
Shyam S. Doda ◽  
Rakesh K. Mathur ◽  
Tarvinder S. Buxi

Sign in / Sign up

Export Citation Format

Share Document